Richard Greil

Richard Greil

UNVERIFIED PROFILE

Are you Richard Greil?   Register this Author

Register author
Richard Greil

Richard Greil

Publications by authors named "Richard Greil"

Are you Richard Greil?   Register this Author

100Publications

2671Reads

22Profile Views

Lignans and sesquiterpene lactones from Hypochaeris radicata subsp. neapolitana (Asteraceae, Cichorieae).

Phytochemistry 2019 Sep 13;165:112047. Epub 2019 Jun 13.

Pharmazeutisches Institut, Abteilung Pharmazeutische Biologie, Christian-Albrechts-Universität zu Kiel, Gutenbergstraße 76, 24118, Kiel, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phytochem.2019.05.020DOI Listing
September 2019

Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.

Anticancer Res 2019 Sep;39(9):4589-4596

Third Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumatology, Oncology Centre, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.13638DOI Listing
September 2019

Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.

Therap Adv Gastroenterol 2019 23;12:1756284819877635. Epub 2019 Sep 23.

Department of Radiation Oncology, Kantonsspital St. Gallen, Rorschacher Strasse 95, St. Gallen, 9007, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756284819877635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759720PMC
September 2019

Mouse models to decipher anti-tumor immunity.

Oncotarget 2019 Aug 20;10(49):5005-5006. Epub 2019 Aug 20.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria; Cancer Cluster Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707950PMC
August 2019

Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.

J Clin Med 2019 Jul 10;8(7). Epub 2019 Jul 10.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8071014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678702PMC
July 2019

Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding - a case report.

Scott Med J 2019 Jul 19:36933019862155. Epub 2019 Jul 19.

7 Head of Department and Professor of Medicine, Department of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0036933019862155DOI Listing
July 2019

Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis.

Support Care Cancer 2019 Jul 26. Epub 2019 Jul 26.

Paracelsus Medizinische Privatuniversität, Salzburger Landeskliniken - Universitätsklinikum Salzburg, Salzburg Cancer Research Institute, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04988-7DOI Listing
July 2019

Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.

Clin Colorectal Cancer 2019 Jun 11;18(2):159-166.e3. Epub 2019 Apr 11.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology, and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute, Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15330028183055
Publisher Site
http://dx.doi.org/10.1016/j.clcc.2019.04.003DOI Listing
June 2019

Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.

PLoS One 2018 20;13(12):e0208753. Epub 2018 Dec 20.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria, Cancer Cluster Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0208753PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301619PMC
May 2019

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.

Eur J Haematol 2019 May 28;102(5):437-441. Epub 2019 Feb 28.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster Salzburg, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13218DOI Listing
May 2019

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.

Theranostics 2018 11;8(8):2278-2288. Epub 2018 Mar 11.

III rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (CCCIT); Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/thno.23544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928889PMC
April 2019

Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.

Leukemia 2019 04 27;33(4):957-968. Epub 2018 Sep 27.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0260-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477797PMC
April 2019

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.

PLoS One 2018 9;13(11):e0206688. Epub 2018 Nov 9.

IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0206688PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226156PMC
April 2019

BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.

Clin Cancer Res 2019 Mar 28;25(6):1901-1912. Epub 2018 Nov 28.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1548DOI Listing
March 2019

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer.

Int J Mol Sci 2019 Mar 5;20(5). Epub 2019 Mar 5.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20051115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429068PMC
March 2019

Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?

Cancers (Basel) 2019 Feb 21;11(2). Epub 2019 Feb 21.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg 5020, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11020252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406956PMC
February 2019

Cytotoxic Properties of Damiana () Extracts and Constituents and A Validated Quantitative UHPLC-DAD Assay.

Molecules 2019 Feb 28;24(5). Epub 2019 Feb 28.

Department of Pharmaceutical Biology, Kiel University, Gutenbergstraße 76, 24118 Kiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules24050855DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429218PMC
February 2019

Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.

Future Oncol 2019 Jan 16;15(2):109-120. Epub 2018 Aug 16.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology & Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory of Immunological & Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria, Cancer Cluster Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0492DOI Listing
January 2019

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).

Breast Cancer Res 2019 01 31;21(1):19. Epub 2019 Jan 31.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-1091-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357474PMC
January 2019

Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.

World Neurosurg 2018 Dec 22;120:442-447. Epub 2018 Sep 22.

Department of Neurosurgery, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2018.09.082DOI Listing
December 2018

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.

Cancer Med 2018 12 10;7(12):5962-5972. Epub 2018 Nov 10.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308077PMC
December 2018

Remission maintenance treatment options in chronic lymphocytic leukemia.

Cancer Treat Rev 2018 Nov 10;70:56-66. Epub 2018 Aug 10.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Austria; Salzburg Cancer Research Institute and Cancer Cluster Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.08.003DOI Listing
November 2018

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).

BMC Cancer 2018 Nov 6;18(1):1074. Epub 2018 Nov 6.

IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-
Publisher Site
http://dx.doi.org/10.1186/s12885-018-4979-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220453PMC
November 2018

ASCO 2018 highlights: metastatic breast cancer.

Memo 2018 20;11(4):276-279. Epub 2018 Nov 20.

1IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-018-0450-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280779PMC
November 2018

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.

J Clin Oncol 2018 09 10;36(25):2603-2611. Epub 2018 Jul 10.

Stephanie Sasse, Helen Goergen, Annette Plütschow, Boris Böll, Dennis A. Eichenauer, Michael Fuchs, Karolin Behringer, Christian Baues, Andreas Engert, Peter Borchmann, and Bastian von Tresckow, University Hospital of Cologne, Cologne; Max S. Topp, University Hospital of Würzburg, Würzburg; Julia Meissner, University of Heidelberg, Heidelberg; Andreas Neubauer, Philipps University, Marburg, Germany; Joseé M. Zijlstra, VU University Medical Center, Amsterdam, the Netherlands; Richard Greil, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute and Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria; and Jana Markova, Charles University in Prague and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.7192DOI Listing
September 2018

Risks and chances of aberrant DNA repair in cancer.

Oncoscience 2018 Sep 22;5(9-10):256-257. Epub 2018 Aug 22.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncoscience.459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231446PMC
September 2018

Cure in metastatic breast cancer.

Memo 2018 17;11(3):172-179. Epub 2018 Aug 17.

1IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-018-0426-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132799PMC
August 2018

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis.

Memo 2018 21;11(3):208-212. Epub 2018 Aug 21.

1IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-018-0433-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132796PMC
August 2018

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

Eur J Cancer 2018 04 20;93:69-78. Epub 2018 Mar 20.

IIIrd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria; Salzburg Cancer Research Institute, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183007
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.01.064DOI Listing
April 2018

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.

Oncotarget 2018 Apr 17;9(29):20928-20940. Epub 2018 Apr 17.

IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelsus Medical University, A-5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945535PMC
April 2018

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.

Mol Cancer Res 2018 03 8;16(3):428-438. Epub 2017 Dec 8.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Austria.

View Article

Download full-text PDF

Source
http://mcr.aacrjournals.org/lookup/doi/10.1158/1541-7786.MCR
Publisher Site
http://dx.doi.org/10.1158/1541-7786.MCR-17-0373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837005PMC
March 2018

Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.

Blood 2018 03 19;131(12):1337-1349. Epub 2018 Jan 19.

Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-08-802462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865232PMC
March 2018

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.

Wien Klin Wochenschr 2018 Feb 30;130(3-4):115-125. Epub 2018 Jan 30.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory of Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Muellner Hauptstraße 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-018-1315-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816094PMC
February 2018

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).

BMC Cancer 2018 01 3;18(1):11. Epub 2018 Jan 3.

IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3955-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753540PMC
January 2018

Antiangiogenic therapy in breast cancer.

Memo 2017 6;10(4):194-201. Epub 2017 Nov 6.

IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0362-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725520PMC
November 2017

ASCO-update: gastrointestinal tumors.

Memo 2017 13;10(4):240-243. Epub 2017 Nov 13.

IIIrd Medical Department of Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Disease, Salzburg Cancer Research Institute (SCRI), Paracelsus Medical University, Muellner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0366-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725513PMC
November 2017

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation : Results of a longitudinal observational study.

Wien Klin Wochenschr 2017 Oct 15;129(19-20):692-701. Epub 2017 Sep 15.

Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-017-1266-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630652PMC
October 2017

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.

Anticancer Res 2017 10;37(10):5553-5558

IIIrd Medical Department at the Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11987DOI Listing
October 2017

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.

Memo 2017 20;10(4):220-223. Epub 2017 Oct 20.

Third Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0358-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725515PMC
October 2017

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

Oncoimmunology 2017 21;7(1):e1371399. Epub 2017 Sep 21.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1371399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739567PMC
September 2017

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

J Clin Oncol 2017 Aug 20;35(22):2473-2481. Epub 2017 Apr 20.

Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis; Diderot University, Sorbonne Paris-Cité; Catherine Thieblemont and Josette Briere, Descartes University; Josette Briere, Hôpital Necker, Paris; Hervé Tilly, University of Rouen, Institut National de la Santé et de la Recherche Médicale U1245, Rouen; Rene-Olivier Casasnovas, Centre Hospitalier Universitaire Dijon; Institut National de la Santé et de la Recherche Médicale UMR1231, Dijon; Christophe Fruchart, Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire, Caen; Franck Morschhauser, Centre Hospitalier Universitaire Régional de Lille, Lille; Corinne Haioun and Philippe Gaulard, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Mondor; Philippe Gaulard, Institut National de la Santé et de la Recherche Médicale U955; Université Paris-Est, Créteil; Julien Lazarovici, Gustave Roussy Cancer Center, Villejuif; Aurore Perrot, University Hospital, Vandoeuvre les Nancy; Catherine Sebban, Centre Leon Berard, University Claude Bernard Lyon 1; Gilles Salles, Hospices Civils de Lyon, Université Claude Bernard U1052, Lyon; Hugo Gonzalez, Centre Hospitalier René Dubos, Pontoise; Reda Bouabdallah, Institut Paoli Calmettes, Marseille; Lucie Oberic, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse; Bernadette Corront, Centre Hospitalier Régional Annecy, Annecy; Bachra Choufi, Centre Hospitalier Dr Duchenne, Boulogne-sur-mer; Gilles Salles and Bertrand Coiffier, Institut National de la Santé et de la Recherche Médicale U1052, Hospices Civils de Lyon, Pierre-Benite, France; Maria Gomes da Silva and Jose Cabeçadas, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal; Anida Grosicka, Medical University of Silesia, Katowice, Poland; Judith Trotman, Concord Repatriation General Hospital, University of Sydney, Concord; John Catalano, Frankston Hospital and Monash University, Frankston, Australia; Dolores Caballero, Hospital Universitario de Salamanca, Salamanca; Armando Lopez-Guillermo, Hospital Clinic Barcelona, Barcelona, Spain; Richard Greil, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute; Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria; Koen van Eygen, Algemeen Ziekenhuis Groeninge Hospital, President Kennedylaan 4, Kortrijk; Achiel Van Hoof, Algemeen Ziekenhuis Sint Jan AV, Brugge; Andre Bosly, UCL Mont Godinne, Yvoir, Belgium; and Amos M. Cohen, Rabin Medical Center, Beilinson Hospital, Davidoff Cancer Center, Tel-Aviv University, Ramat-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6984DOI Listing
August 2017

Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy.

Reprod Toxicol 2017 08 25;71:146-149. Epub 2017 May 25.

Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charité Universitätsmedizin, Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reprotox.2017.05.008DOI Listing
August 2017

Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.

J Acquir Immune Defic Syndr 2017 05;75(1):e13-e20

*Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Laboratory of Immunological and Molecular Cancer Research, Paracelsus Medical University, Salzburg, Austria; †Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria; ‡Department of Laboratory Medicine, Medical University Vienna, Vienna, Austria; §Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria; ‖Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria; and ¶Institute of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298192PMC
May 2017

SABCS 2016: systemic therapy for metastatic breast cancer.

Memo 2017 4;10(2):86-89. Epub 2017 Apr 4.

IIIrd Medical Department, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0326-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493725PMC
April 2017

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.

Cell Commun Signal 2017 03 31;15(1):13. Epub 2017 Mar 31.

3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, A-5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12964-017-0168-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374693PMC
March 2017

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.

Wien Klin Wochenschr 2017 Feb;129(3-4):141-144

IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumathology, Oncologic Center, Paracelsus Medical University, Muellner Hauptstraße 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-016-1124-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318479PMC
February 2017

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.

Blood 2017 01 22;129(3):383-385. Epub 2016 Nov 22.

Clinical Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-06-720599DOI Listing
January 2017

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.

Cell Commun Signal 2017 Jan 19;15(1). Epub 2017 Jan 19.

Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, A-5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12964-016-0155-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244547PMC
January 2017

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.

J Clin Oncol 2016 12 31;34(36):4329-4337. Epub 2016 Oct 31.

Karolin Behringer, Helen Goergen, Horst Müller, Indra Thielen, Corinne Brillant, Stefanie Kreissl, Michael Fuchs, Volker Diehl, Andreas Engert, and Peter Borchmann, University Hospital of Cologne; Jens Ulrich Rueffer, German Fatigue Society, Cologne; Teresa Veronika Halbsguth, University Hospital of Frankfurt, Frankfurt; Julia Meissner, University of Heidelberg, Heidelberg; Hans-Henning Flechtner, Otto von Guericke University, Magdeburg, Germany; Richard Greil, Paracelsus Medical University, Salzburg, Austria; Peter Moosmann, Cantonal Hospital Aarau AG, Aarau and Swiss Group for Clinical Cancer Research, Berne, Switzerland; and Oluwatoyin Shonukan, Boston University School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.7450DOI Listing
December 2016

Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.

Front Neurol 2016 7;7:196. Epub 2016 Nov 7.

Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Salzburg, Austria; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2016.00196DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098172PMC
November 2016

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.

Anticancer Res 2016 09;36(9):4715-23

Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna)-LB-CTO and Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna), Kaiser Franz Josef-Spital, 3rd Medical Department, Center for Oncology and Hematology, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11026DOI Listing
September 2016

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.

Oncotarget 2016 Aug;7(31):49459-49469

Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.10372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226521PMC
August 2016

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?

Int J Mol Sci 2016 Jun 27;17(7). Epub 2016 Jun 27.

3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms17071009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964385PMC
June 2016

CDK4/6 inhibition in luminal breast cancer.

Memo 2016;9:76-81. Epub 2016 Jun 20.

IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria ; Laboratory of Immunological and Molecular Cancer Research, Center for Clinical Cancer and Immunology Trials, Salzburg Cancer Research Institute, Salzburg, Austria ; Cancer Cluster Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-016-0268-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923084PMC
June 2016

Immune checkpoint blockade in ovarian cancer.

Memo 2016;9:82-84. Epub 2016 Jun 2.

3rd Medical Department of Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Disease, Salzburg Cancer Research Institute (SCRI), Muellner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-016-0267-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923079PMC
June 2016